Srinivasan A - Search Results

1

In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake.

Lewis JS, Srinivasan A, Schmidt MA, Anderson CJ. Lewis JS, et al. Among authors: srinivasan a. Nucl Med Biol. 1999 Apr;26(3):267-73. doi: 10.1016/s0969-8051(98)00105-x. Nucl Med Biol. 1999. PMID: 10363797

2

Radiotherapeutic efficacy of (153)Sm-CMDTPA-Tyr(3)-octreotate in tumor-bearing rats.

Bugaj JE, Erion JL, Johnson MA, Schmidt MA, Srinivasan A. Bugaj JE, et al. Among authors: srinivasan a. Nucl Med Biol. 2001 Apr;28(3):327-34. doi: 10.1016/s0969-8051(01)00197-4. Nucl Med Biol. 2001. PMID: 11323245

3

Toxicity and dosimetry of (177)Lu-DOTA-Y3-octreotate in a rat model.

Lewis JS, Wang M, Laforest R, Wang F, Erion JL, Bugaj JE, Srinivasan A, Anderson CJ. Lewis JS, et al. Among authors: srinivasan a. Int J Cancer. 2001 Dec 15;94(6):873-7. doi: 10.1002/ijc.1540. Int J Cancer. 2001. PMID: 11745491

4

Identification of the soluble in vivo metabolites of indium-111-diethylenetriaminepentaacetic acid-D-Phe1-octreotide.

Bass LA, Lanahan MV, Duncan JR, Erion JL, Srinivasan A, Schmidt MA, Anderson CJ. Bass LA, et al. Among authors: srinivasan a. Bioconjug Chem. 1998 Mar-Apr;9(2):192-200. doi: 10.1021/bc970158h. Bioconjug Chem. 1998. PMID: 9548534

5

Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy.

Lewis JS, Lewis MR, Srinivasan A, Schmidt MA, Wang J, Anderson CJ. Lewis JS, et al. Among authors: srinivasan a. J Med Chem. 1999 Apr 22;42(8):1341-7. doi: 10.1021/jm980602h. J Med Chem. 1999. PMID: 10212119

6

Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.

Lewis JS, Lewis MR, Cutler PD, Srinivasan A, Schmidt MA, Schwarz SW, Morris MM, Miller JP, Anderson CJ. Lewis JS, et al. Among authors: srinivasan a. Clin Cancer Res. 1999 Nov;5(11):3608-16. Clin Cancer Res. 1999. PMID: 10589778

7

Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.

Achilefu S, Srinivasan A, Schmidt MA, Jimenez HN, Bugaj JE, Erion JL. Achilefu S, et al. Among authors: srinivasan a. J Med Chem. 2003 Jul 17;46(15):3403-11. doi: 10.1021/jm030081k. J Med Chem. 2003. PMID: 12852770

8

[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy.

de Jong M, Breeman WA, Bernard BF, Bakker WH, Schaar M, van Gameren A, Bugaj JE, Erion J, Schmidt M, Srinivasan A, Krenning EP. de Jong M, et al. Among authors: srinivasan a. Int J Cancer. 2001 Jun 1;92(5):628-33. doi: 10.1002/1097-0215(20010601)92:5<628::aid-ijc1244>3.0.co;2-l. Int J Cancer. 2001. PMID: 11340564

9

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients.

Kwekkeboom DJ, Bakker WH, Kooij PP, Konijnenberg MW, Srinivasan A, Erion JL, Schmidt MA, Bugaj JL, de Jong M, Krenning EP. Kwekkeboom DJ, et al. Among authors: srinivasan a. Eur J Nucl Med. 2001 Sep;28(9):1319-25. doi: 10.1007/s002590100574. Eur J Nucl Med. 2001. PMID: 11585290

10

Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.

de Visser M, Janssen PJ, Srinivasan A, Reubi JC, Waser B, Erion JL, Schmidt MA, Krenning EP, de Jong M. de Visser M, et al. Among authors: srinivasan a. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1134-9. doi: 10.1007/s00259-003-1189-y. Epub 2003 May 24. Eur J Nucl Med Mol Imaging. 2003. PMID: 12768332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,937 results

Search Page

Filters